Marksans Pharma Limited, together with its subsidiaries, engages in the research and development, manufacturing, marketing, distribution, and sale of generic pharmaceutical formulations worldwide. The company offers products in the analgesics, benign prostatic hyperplasia, antidiabetic, epilepsy, anti-inflammatory, hyperparathyroidism, diabetes, antacids, neurology, cardiovascular, hormonal, oncology, gastroenterology, antidiabetic, pain management, gynecology, antibiotic, antifungal, antiulceratives, vitamins, dermatology, cephalosporins, injectables, anti-allergy, antibacterial, and hypertension therapeutic areas. It also provides contract research and manufacturing services. Marksans Pharma Limited was incorporated in 1992 and is headquartered in Mumbai, India.
Dividend history for Marksans Pharma Limited (MARKSANS.NS)
Marksans Pharma Limited made a total of 11 dividend payments.
The sum of all dividends (adjusted for stock splits) is : $0.03
Dividend payments for Marksans Pharma Limited (MARKSANS.NS) from 2014 to 2024
Annual dividend payments
| Date | Dividend | Adj Dividend |
|---|---|---|
| September 17, 24 | $0.01 | $0.01 |
| June 07, 23 | $0.01 | $0.01 |
| August 19, 22 | $0.00 | $0.00 |
| September 15, 21 | $0.00 | $0.00 |
| September 22, 20 | $0.00 | $0.00 |
| September 19, 19 | $0.00 | $0.00 |
| September 19, 18 | $0.00 | $0.00 |
| September 19, 17 | $0.00 | $0.00 |
| September 22, 16 | $0.00 | $0.00 |
| September 23, 15 | $0.00 | $0.00 |
| September 18, 14 | $0.00 | $0.00 |